| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |